22.07.2013 Views

2010 Neurological Institute Outcomes - Cleveland Clinic

2010 Neurological Institute Outcomes - Cleveland Clinic

2010 Neurological Institute Outcomes - Cleveland Clinic

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

82<br />

Neuromuscular Disorders<br />

Quality of Life in Myasthenia Gravis Patients (N = 26)<br />

<strong>2010</strong><br />

Mean MG-QOL15 Score<br />

25<br />

20<br />

15<br />

10<br />

5<br />

0<br />

Mean MG-ADL Score<br />

5<br />

4<br />

3<br />

2<br />

1<br />

0<br />

First Last<br />

Visit<br />

Myasthenia Gravis Functional Status (N = 95)<br />

2009 – <strong>2010</strong><br />

First Last<br />

Visit<br />

The MG-QOL15 is a quality-of-life<br />

questionnaire specific to myasthenia<br />

gravis (MG) that assesses both physical<br />

and psychological aspects of function.<br />

The MG-QOL15 has been shown to<br />

correlate well with clinical outcomes<br />

using physician impression as the gold<br />

standard. There is a reduction in mean<br />

MG-QOL15 from first to last visit. Average<br />

time between visits was 88 days.<br />

The MG-ADL profile is a simple eightitem<br />

questionnaire that focuses on<br />

common symptoms reported in MG.<br />

The graph shows the average score of<br />

95 patients with MG who were seen in<br />

the outpatient clinic by neuromuscular<br />

staff and who had complete MG-ADL<br />

assessments on at least two occasions<br />

in 2009-<strong>2010</strong>. There was a significant<br />

reduction in MG-related symptoms<br />

(P < 0.0001). Average time between<br />

visits was 189 days. Higher scores<br />

indicate greater disability.<br />

<strong>Outcomes</strong> <strong>2010</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!